{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33711289",
  "DateCompleted": {
    "Year": "2021",
    "Month": "04",
    "Day": "26"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "11",
    "Day": "29"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "03",
        "Day": "10"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/S2468-1253(21)00075-3",
      "S2468-1253(21)00075-3"
    ],
    "Journal": {
      "ISSN": "2468-1253",
      "JournalIssue": {
        "Volume": "6",
        "Issue": "5",
        "PubDate": {
          "Year": "2021",
          "Month": "May"
        }
      },
      "Title": "The lancet. Gastroenterology & hepatology",
      "ISOAbbreviation": "Lancet Gastroenterol Hepatol"
    },
    "ArticleTitle": "The impact of SARS-CoV-2 variants on IBD management.",
    "Pagination": {
      "StartPage": "343",
      "EndPage": "344",
      "MedlinePgn": "343-344"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Gastroenterology and Hepatology, Hillingdon Hospital, Uxbridge UB8 3NN, UK. Electronic address: jonathansegal1@nhs.net."
          }
        ],
        "LastName": "Segal",
        "ForeName": "Jonathan P",
        "Initials": "JP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Royal Wolverhampton Trust New Cross Hospital, Wolverhampton, UK."
          }
        ],
        "LastName": "Kumar",
        "ForeName": "Aditi",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Gastroenterology, Cambridge University Hospitals, Cambridge, UK."
          }
        ],
        "LastName": "Raine",
        "ForeName": "Timothy",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK."
          }
        ],
        "LastName": "Lamb",
        "ForeName": "Christopher A",
        "Initials": "CA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Science and Engineering, University of Wolverhampton, Wolverhampton, UK; Department of Gastroenterology, Royal Wolverhampton NHS Trust, Wolverhampton, UK."
          }
        ],
        "LastName": "Brookes",
        "ForeName": "Matthew J",
        "Initials": "MJ"
      }
    ],
    "PublicationTypeList": [
      "Letter"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Lancet Gastroenterol Hepatol",
    "NlmUniqueID": "101690683"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Immunosuppressive Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adaptive Immunity"
    },
    {
      "QualifierName": [
        "epidemiology",
        "immunology",
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunogenicity, Vaccine"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Immunosuppressive Agents"
    },
    {
      "QualifierName": [
        "epidemiology",
        "therapy"
      ],
      "DescriptorName": "Inflammatory Bowel Diseases"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Patient Care"
    },
    {
      "QualifierName": [
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "United Kingdom"
    }
  ]
}